Adverse events234

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 234

Type	Event	Organ system	Group	Affected	At risk
other	Abdomen, pain	Gastrointestinal disorders	Cohort A-Sunitinib Intermittent Dosing	1	21
other	Abdomen, pain	Gastrointestinal disorders	Cohort B-Sunitinib Continuous Dosing	0	31
other	Alkaline phosphatase	Investigations	Cohort A-Sunitinib Intermittent Dosing	1	21
other	Alkaline phosphatase	Investigations	Cohort B-Sunitinib Continuous Dosing	2	31
other	Alopecia	Skin and subcutaneous tissue disorders	Cohort A-Sunitinib Intermittent Dosing	2	21
other	Alopecia	Skin and subcutaneous tissue disorders	Cohort B-Sunitinib Continuous Dosing	0	31
other	ALT, SGPT	Investigations	Cohort A-Sunitinib Intermittent Dosing	2	21
other	ALT, SGPT	Investigations	Cohort B-Sunitinib Continuous Dosing	3	31
other	Amylase	Investigations	Cohort A-Sunitinib Intermittent Dosing	3	21
other	Amylase	Investigations	Cohort B-Sunitinib Continuous Dosing	3	31
other	Anorexia	Metabolism and nutrition disorders	Cohort A-Sunitinib Intermittent Dosing	6	21
other	Anorexia	Metabolism and nutrition disorders	Cohort B-Sunitinib Continuous Dosing	5	31
other	Ascites (non-malignant)	Gastrointestinal disorders	Cohort A-Sunitinib Intermittent Dosing	0	21
other	Ascites (non-malignant)	Gastrointestinal disorders	Cohort B-Sunitinib Continuous Dosing	1	31
other	AST, SGOT	Investigations	Cohort A-Sunitinib Intermittent Dosing	4	21
other	AST, SGOT	Investigations	Cohort B-Sunitinib Continuous Dosing	7	31
other	Bicarbonate	Metabolism and nutrition disorders	Cohort A-Sunitinib Intermittent Dosing	1	21
other	Bicarbonate	Metabolism and nutrition disorders	Cohort B-Sunitinib Continuous Dosing	0	31
other	Bronchopulmonary, hemorrhage	Respiratory, thoracic and mediastinal disorders	Cohort A-Sunitinib Intermittent Dosing	1	21
other	Bronchopulmonary, hemorrhage	Respiratory, thoracic and mediastinal disorders	Cohort B-Sunitinib Continuous Dosing	0	31

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00577382/events

API reference For AI assistants

Adverse events234

Sources 3

Read this list from software.